{
    "clinical_study": {
        "@rank": "89105", 
        "arm_group": {
            "arm_group_label": "Combigan\u00ae Ophthalmic Solution", 
            "description": "Patients treated with Combigan\u00ae Ophthalmic Solution as per local standard of care in clinical practice."
        }, 
        "brief_summary": {
            "textblock": "This study is a Post-Marketing Surveillance study in Korea to evaluate the safety and\n      efficacy of Combigan\u00ae (brimonidine tartrate/timolol maleate) Ophthalmic Solution in patients\n      with Open Angle Glaucoma or Ocular hypertension with insufficient response to local beta\n      blockers treated as per standard of care in clinical practice."
        }, 
        "brief_title": "Safety and Efficacy of Combigan\u00ae Ophthalmic Solution in Korea", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "Patients treated with Combigan\u00ae Ophthalmic Solution as per local standard of care in clinical practice.", 
                        "title": "Combigan\u00ae Ophthalmic Solution"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "732"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "140"
                                            }
                                        }, 
                                        "sub_title": "< 50 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "144"
                                            }
                                        }, 
                                        "sub_title": "50 - 59 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "219"
                                            }
                                        }, 
                                        "sub_title": "60 - 69 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "225"
                                            }
                                        }, 
                                        "sub_title": "\u2265 70 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "4"
                                            }
                                        }, 
                                        "sub_title": "Missing Data"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age, Customized", 
                            "units": "Participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "347"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "384"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "1"
                                            }
                                        }, 
                                        "sub_title": "Missing Data"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender, Customized", 
                            "units": "Participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "An adverse event was any unfavorable and unintended sign, symptom, or disease associated with the use of the study drug, whether or not considered related to the study drug.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Patients treated with Combigan\u00ae Ophthalmic Solution as per local standard of care in clinical practice.", 
                                "title": "Combigan\u00ae Ophthalmic Solution"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "732"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6.56"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "An adverse event was any unfavorable and unintended sign, symptom, or disease associated with the use of the study drug, whether or not considered related to the study drug.", 
                                    "param": "Number", 
                                    "title": "Percentage of Participants Reporting Adverse Events", 
                                    "units": "Percentage of participants"
                                }
                            ]
                        }, 
                        "population": "Safety Population included all participants who received study drug.", 
                        "safety_issue": "No", 
                        "time_frame": "Up to 2.6 Years", 
                        "title": "Percentage of Participants Reporting Adverse Events", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "IOP is a measurement of the fluid pressure inside the eye. The study doctor classified the overall improvement of the IOP change from Baseline into 3 categories: Improvement (effective), No Change or Exacerbation (ineffective). The percentage of participants with Improvement is reported.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Patients treated with Combigan\u00ae Ophthalmic Solution as per local standard of care in clinical practice.", 
                                "title": "Combigan\u00ae Ophthalmic Solution"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "699"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "85.69"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "IOP is a measurement of the fluid pressure inside the eye. The study doctor classified the overall improvement of the IOP change from Baseline into 3 categories: Improvement (effective), No Change or Exacerbation (ineffective). The percentage of participants with Improvement is reported.", 
                                    "param": "Number", 
                                    "title": "Percentage of Participants With Overall Improvement From Baseline in Intraocular Pressure (IOP)", 
                                    "units": "Percentage of participants"
                                }
                            ]
                        }, 
                        "population": "Efficacy Population included all participants who received study drug for > 4 weeks and had overall assessment data available.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 4", 
                        "title": "Percentage of Participants With Overall Improvement From Baseline in Intraocular Pressure (IOP)", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "Patients treated with Combigan\u00ae Ophthalmic Solution as per local standard of care in clinical practice.", 
                        "title": "Combigan\u00ae Ophthalmic Solution"
                    }
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "732", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "732", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "0", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "email": "clinicaltrials@allergan.com", 
                "name_or_title": "Vice President  GSE,", 
                "organization": "Allergan, Inc", 
                "phone": "714-246-4500"
            }
        }, 
        "completion_date": {
            "#text": "November 2011", 
            "@type": "Actual"
        }, 
        "condition": [
            "Glaucoma, Open-Angle", 
            "Ocular Hypertension"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Glaucoma", 
                "Glaucoma, Open-Angle", 
                "Hypertension", 
                "Ocular Hypertension"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with Open Angle Glaucoma or Ocular Hypertension treated with Combigan\u00ae\n             Ophthalmic Solution as standard of care in clinical practice.\n\n        Exclusion Criteria:\n\n          -  None."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with Open Angle Glaucoma or Ocular Hypertension treated with Combigan\u00ae Ophthalmic\n        Solution in Clinical practice."
            }
        }, 
        "enrollment": {
            "#text": "732", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 13, 2013", 
        "firstreceived_results_date": "February 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01987752", 
            "org_study_id": "190342-040"
        }, 
        "intervention": {
            "arm_group_label": "Combigan\u00ae Ophthalmic Solution", 
            "description": "brimonidine tartrate/timolol maleate (Combigan\u00ae) Ophthalmic Solution as per local standard of care in clinical practice.", 
            "intervention_name": "brimonidine tartrate/timolol maleate Ophthalmic Solution", 
            "intervention_type": "Drug", 
            "other_name": "Combigan\u00ae"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Timolol", 
                "Brimonidine", 
                "Maleic acid"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "February 25, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "1", 
        "overall_official": {
            "affiliation": "Allergan", 
            "last_name": "Medical Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "An adverse event was any unfavorable and unintended sign, symptom, or disease associated with the use of the study drug, whether or not considered related to the study drug.", 
                "measure": "Percentage of Participants Reporting Adverse Events", 
                "safety_issue": "No", 
                "time_frame": "Up to 2.6 Years"
            }, 
            {
                "description": "IOP is a measurement of the fluid pressure inside the eye. The study doctor classified the overall improvement of the IOP change from Baseline into 3 categories: Improvement (effective), No Change or Exacerbation (ineffective). The percentage of participants with Improvement is reported.", 
                "measure": "Percentage of Participants With Overall Improvement From Baseline in Intraocular Pressure (IOP)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 4"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01987752"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Allergan", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Allergan", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2009", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}